ReportsnReports.com adds report Biochips Market in North America 2014-2018 to its store. North America to grow at a CAGR of 10.24 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need for high-speed diagnosis. The Biochips market in North America has also been witnessing the increasing outsourcing activities by drug manufacturers. However, the high cost incurred in the implementation of biochips could pose a challenge to the growth of this market.
Over the years, a large number of drug manufacturers have been outsourcing their drug development processes to contract research organizations. Outsourcing activities reduce manufacturing and distribution costs, ensure quality of service, and reduce lead time. They also help the sourcing companies manage product demand and concentrate on other competencies such as innovation and brand building. These contract research organizations employ the latest technologies and sophisticated instruments, and thus increased outsourcing to such organizations is a positive trend driving the market.
Purchase Report Directly @ http://www.reportsnreports.com/Purchase.aspx?name=273329.
According to the report, one of the main drivers of this market is the increased need for high-speed diagnosis for patients and doctors. Biochips are specially designed with advanced technology that makes them ultra-efficient, thus enhancing their operating speed to a great extent.
Further, the report states that one of the major challenges is the high cost incurred in the implementation of biochips. The development process of biochips is lengthy as it needs to go through various stages such as design, testing, and implementation. This process is time- consuming and expensive.Biochips Market in North America 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on North America; it also covers the Biochips market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space are Abbott Laboratories, Affymetrix Inc., Agilent Technologies Inc., Becton, Dickinson and Co., bioMérieux S.A., BioRad Laboratories, Cepheid Inc., Danaher Corp., GE Healthcare Ltd., Microarrays Inc., Qiagen N.V, Promega Corp., Illumina Inc., Life Technologies Corp., Roche Holding AG, Perkin Elmer Inc., and Siemens Healthcare Diagnostics.
Key questions answered in this report:
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details on email@example.com and we would be happy to help you find the business intelligence that you need. Not limited to the Biotechnology ReportsnReports.com offers research studies on agriculture, consumer goods, environment, advanced materials, public sector, food and beverages, energy and power, medical devices, healthcare, automotive, manufacturing & construction, semiconductor and electronics, IT & telecommunication, pharmaceuticals, retail, water, banking and financial services , advanced materials and much more.